Repeated administration of many addictive drugs leads to a progressive increase in their locomotor effects. This increase in locomotor activity often develops concomitantly with increases in their positive-reinforcing effects, which are believed to contribute to the etiology of substance use disorders. The purpose of this study was to examine changes in sensitivity to the locomotor effects of opioids after their repeated administration and to determine the role of and receptors in mediating these effects. Separate groups of rats were treated with opioid receptor agonists and antagonists every other day for 10 days, and changes in locomotor activity were measured. Repeated administration of the agonists, morphine and buprenorphine, produced a progressive increase in locomotor activity during the treatment period, and this effect was blocked by coadministration of the opioid antagonist naltrexone. The agonist spiradoline decreased locomotor activity when administered alone and blocked the progressive increase in locomotor activity produced by morphine. The ability of spiradoline to block morphine-induced increases in locomotor activity was itself blocked by pretreatment with the antagonist nor-binaltorphimine. Repeated administration of high doses, but not low or moderate doses, of the mixed / agonists butorphanol, nalbuphine, and nalorphine produced a progressive increase in locomotor activity during the treatment period. Doses of butorphanol, nalbuphine, and nalorphine that failed to produce a progressive increase in locomotor activity when administered alone did so when subjects were pretreated with nor-binaltorphimine. These findings suggest that and receptors have functionally opposing effects on opioid-mediated locomotor activity and sensitization-related processes.Locomotor activity after psychotropic drug administration has long been of interest to behavioral pharmacologists in general and substance abuse researchers in particular. The reasons for this interest can be traced to the fact that the anatomical structures and neurotransmitter systems mediating locomotor activity overlap those that mediate positive reinforcement and reward (for review, see Wise, 1987;Tzschentke, 2001). Because of this overlap, a careful examination of locomotor activity after drug administration can shed light on the neuropharmacological basis of substance abuse and other addictive behaviors.Opioid analgesics produce a stereotypical pattern of locomotor activity that has been well characterized. After systemic administration, -opioid agonists initially produce a transient decrease in locomotor activity that gradually dissipates over the course of 60 to 120 min, which is then followed by an increase in locomotor activity lasting several hours (Babbini and Davis, 1972;Buxbaum et al., 1973). Sensitivity to both the initial decrease and the subsequent increase in locomotor activity changes after the repeated administration of opioids, such that the initial decrease becomes gradually smaller, and the subsequent increase becom...